Latest Insider Transactions at Hologic Inc (HOLX)
This section provides a real-time view of insider transactions for Hologic Inc (HOLX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HOLOGIC INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HOLOGIC INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 08
2023
|
Elisabeth A Hellmann SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
244
-2.83%
|
$16,592
$68.27 P/Share
|
|
Nov 08
2023
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
190
-1.32%
|
$12,920
$68.27 P/Share
|
|
Nov 08
2023
|
Erik S Anderson Div. Pres., Breast & Skeletal |
SELL
Payment of exercise price or tax liability
|
Direct |
126
-0.89%
|
$8,568
$68.27 P/Share
|
|
Nov 07
2023
|
Jan Verstreken Group President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
247
-0.31%
|
$16,796
$68.37 P/Share
|
|
Nov 07
2023
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,974
-0.31%
|
$270,232
$68.37 P/Share
|
|
Nov 07
2023
|
Karleen Marie Oberton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
740
-0.6%
|
$50,320
$68.37 P/Share
|
|
Nov 07
2023
|
Essex D Mitchell Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
384
-4.36%
|
$26,112
$68.37 P/Share
|
|
Nov 07
2023
|
Jennifer M Schneiders President, Diag. Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
154
-4.65%
|
$10,472
$68.37 P/Share
|
|
Nov 07
2023
|
John M. Griffin General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
592
-0.35%
|
$40,256
$68.37 P/Share
|
|
Nov 07
2023
|
Elisabeth A Hellmann SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
272
-3.06%
|
$18,496
$68.37 P/Share
|
|
Nov 07
2023
|
Erik S Anderson Div. Pres., Breast & Skeletal |
SELL
Payment of exercise price or tax liability
|
Direct |
343
-3.07%
|
$23,324
$68.37 P/Share
|
|
Nov 07
2023
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
106
-0.73%
|
$7,208
$68.37 P/Share
|
|
Nov 06
2023
|
Jan Verstreken Group President, International |
BUY
Grant, award, or other acquisition
|
Direct |
2,438
+2.93%
|
-
|
|
Nov 06
2023
|
Stephen P Macmillan Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
24,133
+1.86%
|
-
|
|
Nov 06
2023
|
Karleen Marie Oberton Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,633
+3.64%
|
-
|
|
Nov 06
2023
|
Essex D Mitchell Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,463
+14.25%
|
-
|
|
Nov 06
2023
|
John M. Griffin General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
4,145
+2.38%
|
-
|
|
Nov 06
2023
|
Erik S Anderson Div. Pres., Breast & Skeletal |
BUY
Grant, award, or other acquisition
|
Direct |
853
+7.1%
|
-
|
|
Sep 20
2023
|
Nanaz Mohtashami Director |
BUY
Grant, award, or other acquisition
|
Direct |
745
+50.0%
|
-
|
|
Aug 30
2023
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Bona fide gift
|
Direct |
1,064,954
-46.02%
|
-
|
|
Jun 30
2023
|
Jan Verstreken Group President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
322
-0.41%
|
$25,760
$80.97 P/Share
|
|
Jun 15
2023
|
Scott T Garrett Director |
SELL
Open market or private sale
|
Direct |
10,000
-14.92%
|
$790,000
$79.72 P/Share
|
|
May 05
2023
|
Essex D Mitchell Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,390
-24.89%
|
$198,370
$83.73 P/Share
|
|
Mar 09
2023
|
Stacey D. Stewart Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,465
+45.82%
|
-
|
|
Mar 09
2023
|
Amy Mc Bride Wendell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,465
+7.1%
|
-
|
|
Mar 09
2023
|
Ludwig Hantson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,465
+13.34%
|
-
|
|
Mar 09
2023
|
Namal Nawana Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,465
+7.44%
|
-
|
|
Mar 09
2023
|
Christiana Stamoulis Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,465
+3.23%
|
-
|
|
Mar 09
2023
|
Sally Crawford Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,465
+1.1%
|
-
|
|
Mar 09
2023
|
Charles J Dockendorff Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,465
+17.89%
|
-
|
|
Mar 09
2023
|
Scott T Garrett Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,465
+2.14%
|
-
|
|
Mar 01
2023
|
Erik S Anderson Div. Pres., Breast & Skeletal |
SELL
Payment of exercise price or tax liability
|
Direct |
381
-3.56%
|
$30,099
$79.06 P/Share
|
|
Feb 07
2023
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
9,128
-38.97%
|
$775,880
$85.28 P/Share
|
|
Feb 07
2023
|
Benjamin Jordan Cohn Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,128
+28.04%
|
$365,120
$40.97 P/Share
|
|
Feb 07
2023
|
Charles J Dockendorff Director |
SELL
Bona fide gift
|
Indirect |
1,336
-100.0%
|
-
|
|
Jan 02
2023
|
Stacey D. Stewart Director |
BUY
Grant, award, or other acquisition
|
Direct |
267
+50.0%
|
-
|
|
Dec 14
2022
|
Elisabeth A Hellmann SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
1,649
-16.18%
|
$125,324
$76.4 P/Share
|
|
Dec 05
2022
|
John M. Griffin General Counsel |
SELL
Bona fide gift
|
Direct |
2,989
-1.77%
|
-
|
|
Nov 30
2022
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
33,500
-0.72%
|
$2,512,500
$75.72 P/Share
|
|
Nov 15
2022
|
Kevin R Thornal Group Pres, Global Diagnostics |
SELL
Open market or private sale
|
Direct |
19,118
-13.15%
|
$1,433,850
$75.34 P/Share
|
|
Nov 15
2022
|
Kevin R Thornal Group Pres, Global Diagnostics |
BUY
Exercise of conversion of derivative security
|
Direct |
12,490
+14.3%
|
$499,600
$40.85 P/Share
|
|
Nov 14
2022
|
John M. Griffin General Counsel |
SELL
Open market or private sale
|
Direct |
26,902
-6.98%
|
$2,044,552
$76.28 P/Share
|
|
Nov 14
2022
|
John M. Griffin General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
26,902
+12.08%
|
$1,076,080
$40.85 P/Share
|
|
Nov 11
2022
|
John M. Griffin General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
13,141
-7.22%
|
$985,575
$75.93 P/Share
|
|
Nov 11
2022
|
Elisabeth A Hellmann SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
285
-2.72%
|
$21,375
$75.93 P/Share
|
|
Nov 11
2022
|
Essex D Mitchell Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
252
-2.6%
|
$18,900
$75.93 P/Share
|
|
Nov 11
2022
|
Kevin R Thornal Group Pres, Global Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
8,780
-11.29%
|
$658,500
$75.93 P/Share
|
|
Nov 11
2022
|
Jan Verstreken Group President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
1,915
-2.37%
|
$143,625
$75.93 P/Share
|
|
Nov 11
2022
|
Karleen Marie Oberton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,145
-11.39%
|
$1,135,875
$75.93 P/Share
|
|
Nov 11
2022
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
96,355
-3.94%
|
$7,226,625
$75.93 P/Share
|